Skip to content
Credit reportVerdict and grounds
Made on 19-11-2026 at 20:54
Reference CK-0697720802-20261119

EndoCard

ActivePrivate limited company0697.720.802Nieuwenhovedreef 26, 8490 Jabbeke
founded in 2018 · 2 establishment units · financial year to 31 March · accounts in the micro format

Sources: the KBO register on 19-11-2026; the National Bank, annual accounts to 31-03-2026 filed on 23-10-2026; the Belgian Official Gazette, latest deed of 28-11-2024.

Credit verdict
Checked score 2026
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
Gross margin
€998,754
▲ 6.7% against 2025
Net result
€650,049
▲ 5.6% against 2025
Equity
€669,936
▲ 5.7% against 2025
Cash
€328,463
▼ 38.8% against 2025

Grounds

the facts the verdict rests on, each with its source
  1. EndoCard made a profit in every financial year since 2019. The profit of 2026, €650,049, is the highest so far.Annual accounts 2019 to 2026 page 2
  2. Equity stands at €669,936, or 28.1% of the balance sheet total of €2.4m.Annual accounts to 31-03-2026 page 2
  3. EndoCard paid out €614,000 in dividends, 94% of the profit of 2026.Annual accounts to 31-03-2026 page 2
  4. Of the €1.7m of debt, €1.0m runs for more than a year.Annual accounts to 31-03-2026, notes page 2
  5. The last five annual accounts came in on time. The accounts to 31-03-2026 were filed 8 days before the end of the term.National Bank, filing of 23-10-2026 page 4

Representation

The signing rule is in the deed of 31-12-2021.

Articles of association, Belgian Official Gazette of 31-12-2021, deed 21380269

Ownership

The accounts in the micro format list no shareholders. is mandate holder. There is one other shareholder.

Deed of 31-12-2021

EndoCard · 0697.720.802 · credit report of 19-11-2026Page 1 of 5
EndoCard0697.720.802 · report of 19-11-2026

Financial situation

Annual accounts 2022 to 2026, as filed with the National Bank

Gross margin and net resultin €m

20220.620230.620240.920250.920261.020220.420230.220240.620250.620260.7
gross marginnet result

Equity and debtsin €m

202220232024202520260.71.7
equitydebts

Cashin €m

20220.220230.220240.420250.520260.3
on the balance sheet date
Financial year20222023202420252026Trend
Results
Gross margin€558,437€583,744€949,380€936,150€998,754
Operating result€554,884€349,302€879,472€856,040€908,867
Net result€424,035€246,985€645,661€615,287€650,049
Balance sheet at the closing date
Equity€18,600€265,585€666,246€633,887€669,936
Debts€468,537€1.7m€1.7m€1.7m€1.7m
Debts due after more than one year-€1.3m€1.2m€1.1m€1.0m
Debts due within one year€468,537€358,884€421,091€532,652€644,059
Cash€220,921€190,491€363,040€536,829€328,463
Balance sheet total€487,137€2.0m€2.3m€2.3m€2.4m
Ratios
Solvency3.8%13.4%28.7%27.3%28.1%
Liquidity0.901.111.871.481.44

Source: Annual accounts to 31-03-2026, micro format, filed on 23-10-2026 (2026-00568458); Annual accounts to 31-03-2025, micro format, filed on 24-10-2025 (2025-00550396); Annual accounts 2022 to 2024, filed from 27-10-2022 to 25-10-2024 (2022-20476723, 2023-00503663, 2024-00516658).

The annual accounts to 31-03-2026 state no amount of overdue tax or social security (RSZ) debts.

EndoCard states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €936,150 to €998,754.

EndoCard · 0697.720.802 · credit report of 19-11-2026Page 2 of 5
EndoCard0697.720.802 · report of 19-11-2026

Board, signature and ownership

Position on 19-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The signing rule is in the deed of 31-12-2021.

Articles of association, Belgian Official Gazette of 31-12-2021, deed 21380269

Board

two directors in office
Directorsince 05-06-2018
term without a fixed enddeed of 11-06-2018
Managersince 05-06-2018
deed of 11-06-2018

Ownership and group

Shareholders

The accounts in the micro format list no shareholders. is mandate holder. is mandate holder.

Deed of 31-12-2021

Board changes

(director) and (director) reappointed. General meeting of 04-06-2024.

Gazette, deed 24168556
EndoCard · 0697.720.802 · credit report of 19-11-2026Page 3 of 5
EndoCard0697.720.802 · report of 19-11-2026

Events and comparison

Every event since the founding, newest first

Annual accounts 2026 filed, 8 days before the deadline.

NBB filing

Highest result from 2019 to 2026. The operating result of €908,867 and the net result of €650,049 are both a record.

Financial

Annual accounts 2025 filed, 7 days before the deadline.

NBB filing

Annual accounts 2024 filed, 6 days before the deadline.

NBB filing

Annual accounts 2023 filed, 1 day before the deadline.

NBB filing

Weakest financial year. The net result drops to €246,985, the lowest from 2019 to 2026. It recovers the following year.

Financial

Annual accounts 2022 filed, 4 days before the deadline.

NBB filing

Company renamed from Dr. Nick Hiltrop-Dr. to EndoCard. “De uitoefening van de geneeskunde door de artsen-aandeelhouders, meer bepaald van de geneeskunde met…” (deed in Dutch). Partner: (mandate holder). Partner: (mandate holder). General meeting of 21-12-2021.

Gazette, deed 21380269

Annual accounts 2021 filed, 31 days before the deadline.

NBB filing

Annual accounts 2020 filed, 44 days before the deadline.

NBB filing

Equity above €500,000. With a profit in every financial year since 2019, equity grows to €549,144.

Financial

Annual accounts 2019 filed, 3 days before the deadline.

NBB filing

Incorporation. Founding capital of €18,600, 100 shares. Founded by ; . (manager) and (manager) appointed. Published on 11-06-2018.

Gazette, deed 18316826

Bruges and Kortrijk.

Comparable companies, two years later

In July 2024, 2,684 companies had the same profile as EndoCard has now: small, 5 to 10 years old, solvency 10 to 30% and a profit of 5% of the balance sheet or more. Two years later 97.2% were still trading, 1.4% had stopped another way and 1.3% had gone bankrupt.

still trading 97.2% stopped another way 1.4% bankrupt 1.3%

Other findings

Peppol

Reachable for e-invoices since 24-11-2024, under 0208:0697720802.

Sanctions lists

EndoCard · 0697.720.802 · credit report of 19-11-2026Page 4 of 5
EndoCard0697.720.802 · report of 19-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units19-11-2026KBO 0697.720.802
National Bank of BelgiumAnnual accounts to 31-03-2026, micro format23-10-20262026-00568458
National Bank of BelgiumAnnual accounts to 31-03-2025, micro format24-10-20252025-00550396
National Bank of BelgiumAnnual accounts 2022 to 202427-10-2022 to 25-10-20242022-20476723, 2023-00503663, 2024-00516658
Belgian Official GazetteBoard28-11-2024deed 24168556
Belgian Official GazetteArticles of association with the signing rule31-12-2021deed 21380269
Peppol DirectoryRegistration for e-invoices24-11-20240208:0697720802
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies18-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 18-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

EndoCard · 0697.720.802 · credit report of 19-11-2026Page 5 of 5